Fractyl Health, Inc. Common Stock
Price Action
Technical Summary
CONSOLIDATINGFractyl Health, Inc. Common Stock is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 49), showing significant lag compared to the market leaders. Earnings growth of 124% provides fundamental context to the price action. Investors should exercise caution due to high volatility (122% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.78 | +1.90% | ABOVE |
| 50 SMA | $0.76 | +4.45% | ABOVE |
| 100 SMA | $0.61 | +30.17% | ABOVE |
| 150 SMA | $1.04 | -23.40% | BELOW |
| 200 SMA | $1.09 | -26.99% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GUTS in an uptrend right now?
GUTS has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is GUTS overbought or oversold?
GUTS's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is GUTS outperforming the market?
GUTS has a Relative Strength (RS) Rating of 49 out of 99. GUTS is currently lagging the broader market.
Where is GUTS in its 52-week range?
GUTS is trading at $0.80, which is 33% of its 52-week high ($2.44) and 20% above its 52-week low ($0.38).
How volatile is GUTS?
GUTS has a Beta of 1.97 and 52-week volatility of 122%. It's more volatile than the S&P 500 - expect bigger swings.